Skip to Main Content

Paper Details

Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure: A Mendelian Randomization Study.
Clin J Am Soc Nephrol
10
2022
CKD, Chronic Kidney Disease, FGF23, Fibroblast Growth Factor-23, Heart Failure, fibroblast growth factor-23, heart failure, participants, patients, polygenic, polygenic risk
Author NameAffiliation
Eric Farber-EgerVanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center
Eric Farber-EgerVanderbilt University Medical Center
Loren LipworthVanderbilt University Medical Center
Loren LipworthVanderbilt University Medical Center
Edward D SiewVanderbilt University Medical Center
Edward D SiewVanderbilt Tennessee Valley Healthcare System
Nisha BansalVanderbilt Tennessee Valley Healthcare System
Ian H de BoerUniversity of Washington
Ian H de BoerUniversity of Washington
Bryan KestenbaumUniversity of Washington
Nancy J CoxVanderbilt University Medical Center
Nancy J CoxVanderbilt University Medical Center
Talat Alp IkizlerVanderbilt University Medical Center
Quinn S WellsVanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center
Quinn S WellsVanderbilt University Medical Center
Cassianne Robinson-CohenVanderbilt University Medical Center
  • 1 - 16

Datasets

Release 1.2